Starpharma Holdings Limited (AU:SPL) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Starpharma Holdings Limited’s DEP® SN38 shows promising results in treating advanced colorectal and ovarian cancers, as presented at a recent cancer conference. The drug demonstrated sustained disease control and improved quality of life for patients with reduced toxicity compared to standard treatments. These promising Phase 1/2 trial results position DEP® SN38 as a strong candidate for further development and potential commercialization.
For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.
